Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",48551,293,1.32 [1.03-1.69],0.0259410651391286
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50288,388,0.95 [0.75-1.20],0.6634263532252249
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49770,2718,1.08 [0.99-1.18],0.0833460740909641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,50328,830,0.88 [0.75-1.04],0.1459271739497324
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,48799,6862,1.01 [0.95-1.07],0.7349084516795004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49002,6268,1.04 [0.98-1.10],0.2208040343877443
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,49832,2387,1.00 [0.91-1.10],0.9531025988561976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,50147,172,1.14 [0.81-1.60],0.4478499116355792
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46309,1888,1.07 [0.96-1.19],0.2009184312898877
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44749,2154,1.16 [1.06-1.28],0.0021097707348857
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,44502,496,1.04 [0.85-1.29],0.6824513757080942
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35357,3873,1.05 [0.98-1.13],0.1908980491338028
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44203,768,1.13 [0.96-1.33],0.1388015154647404
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,50255,2810,0.99 [0.91-1.08],0.8020668972998124
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,50477,979,0.94 [0.81-1.10],0.453070971394191
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48880,1828,1.14 [1.03-1.26],0.015015366698352
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50345,2087,1.11 [1.01-1.23],0.0316358962161004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47835,390,0.95 [0.75-1.20],0.6680387113787836
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,50577,96,0.95 [0.59-1.53],0.8261987480540265
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,50081,1823,1.09 [0.98-1.21],0.1151445886079247
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50122,147,0.87 [0.59-1.29],0.4901112435742553
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50420,308,1.15 [0.89-1.48],0.2751710085570542
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50383,271,1.16 [0.89-1.51],0.2847809360129637
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47874,822,0.99 [0.84-1.16],0.8839351513635461
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,47596,544,0.94 [0.77-1.15],0.5710741966279347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,47660,215,1.14 [0.84-1.55],0.3971185466700209
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,50535,104,1.17 [0.76-1.80],0.4692671956997494
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50444,300,1.01 [0.78-1.33],0.9146309247470304
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral warts,50242,98,1.05 [0.66-1.66],0.842471155957114
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],50272,128,0.87 [0.57-1.33],0.5170050752252724
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,49996,577,0.85 [0.69-1.03],0.0999140607429896
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50405,117,0.83 [0.53-1.31],0.4284044726596796
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50366,121,1.05 [0.69-1.59],0.8119734118659658
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23250,128,1.20 [0.81-1.77],0.3618078744996923
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49939,2802,0.88 [0.80-0.96],0.0038879239550385
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of meninges,50550,113,1.20 [0.80-1.80],0.3762967447266997
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50444,128,1.09 [0.73-1.63],0.6819594614017446
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,50529,212,0.92 [0.67-1.28],0.632344892373301
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of ovary,27196,177,0.75 [0.52-1.09],0.1334868202078386
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,50533,705,0.79 [0.66-0.95],0.0127966545680149
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Caecum,50533,583,0.80 [0.65-0.97],0.0265108073498688
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50369,142,0.93 [0.62-1.38],0.7077207282762663
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,50527,425,0.85 [0.68-1.08],0.1827292133056211
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,50453,687,0.83 [0.69-1.00],0.0468517572672843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50354,1193,0.85 [0.74-0.97],0.0185719628396101
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,50514,830,0.85 [0.72-1.00],0.0485557697540138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Carcinoma in situ of breast,22115,137,0.96 [0.64-1.43],0.8373342020037239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22202,165,0.90 [0.62-1.30],0.5690746225828872
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40294,103,0.89 [0.55-1.43],0.6275837903984103
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40324,133,1.14 [0.77-1.70],0.5016307814295474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50477,234,0.89 [0.65-1.21],0.4504196419928111
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",50478,229,0.90 [0.66-1.24],0.528827063109331
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Leiomyoma of uterus,26286,584,0.90 [0.74-1.09],0.2732442781699904
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lung cancer and mesothelioma,35065,646,1.20 [1.01-1.43],0.0387900250399197
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lymphoid leukaemia,40293,102,0.97 [0.61-1.56],0.9151238858405852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40560,369,0.96 [0.75-1.23],0.7410624491143973
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",40589,398,0.85 [0.67-1.09],0.2004944993193237
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22335,183,1.07 [0.77-1.51],0.6770280011573759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40347,156,0.86 [0.58-1.26],0.4325902481899965
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40399,208,1.15 [0.84-1.57],0.3887097326361309
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",40386,195,0.67 [0.47-0.96],0.0301490078865209
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22289,137,0.94 [0.63-1.41],0.7772953101267458
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40376,185,1.11 [0.80-1.55],0.5366912356234734
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19406,1367,1.01 [0.89-1.14],0.901915292193102
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",40418,227,1.06 [0.78-1.44],0.7000307411751039
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40336,145,0.81 [0.54-1.22],0.3104010060642446
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,40395,204,1.10 [0.80-1.52],0.5584987848746399
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,50188,391,1.03 [0.82-1.30],0.7873909863216901
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of trunk,50498,170,1.19 [0.85-1.66],0.3075557868780073
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanoma in situ,40258,158,0.90 [0.61-1.33],0.5960320844932496
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40367,176,1.12 [0.79-1.58],0.5195185021310367
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40502,311,1.21 [0.94-1.55],0.13042991530604
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",40632,441,0.99 [0.79-1.24],0.9126271821726714
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",40384,193,1.24 [0.91-1.69],0.1726858594259306
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,50220,303,0.93 [0.71-1.23],0.6181265915659688
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42300,2109,0.94 [0.85-1.04],0.2543388845882187
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",42411,2220,0.94 [0.85-1.04],0.2309327053113508
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50006,669,0.94 [0.79-1.13],0.5306625926910484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,46888,221,1.35 [1.01-1.80],0.0392741400989534
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,49473,136,1.05 [0.71-1.55],0.8105069295921374
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49023,5664,0.94 [0.88-1.00],0.0395297154691385
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,47689,93,0.67 [0.40-1.13],0.1325325834441562
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,49771,97,1.05 [0.66-1.68],0.822881363354683
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,49632,2965,0.92 [0.84-1.01],0.0658917123449414
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,49630,2963,0.92 [0.84-1.01],0.066807136687246
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,46836,169,0.92 [0.64-1.33],0.6615492466907298
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49939,2343,0.98 [0.89-1.08],0.6833290716723437
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,49892,218,0.95 [0.69-1.30],0.7529311426227561
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,49466,129,1.16 [0.79-1.70],0.4570754751165461
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,49454,117,0.53 [0.33-0.85],0.0088440156823889
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,50209,535,1.09 [0.90-1.33],0.3755356958448793
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,50369,110,1.39 [0.94-2.04],0.0963199228335785
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",50115,441,1.02 [0.82-1.27],0.8459085707505579
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,47805,209,0.82 [0.59-1.15],0.2452006495645128
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39153,624,1.10 [0.92-1.31],0.3117822694878538
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,47159,229,0.79 [0.57-1.09],0.1529516015903294
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,47177,247,0.97 [0.72-1.31],0.8614720735260362
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,38637,108,1.30 [0.87-1.95],0.2006684809593848
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,46959,135,0.80 [0.53-1.22],0.3100944594169631
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,45854,462,0.90 [0.72-1.13],0.3627479106120737
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",49640,1110,1.02 [0.88-1.17],0.8015451628546955
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,49059,529,1.12 [0.92-1.37],0.2580109395153778
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,48782,252,0.91 [0.67-1.23],0.5230731505431365
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,49881,3057,0.95 [0.87-1.04],0.2565621389940546
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44061,2966,0.96 [0.88-1.05],0.3502637383345692
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",38654,125,1.13 [0.76-1.67],0.5523753688037234
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",46622,156,0.91 [0.62-1.32],0.6100050341917284
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39085,556,1.09 [0.90-1.32],0.3686182053386887
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,38642,113,1.61 [1.14-2.28],0.0067288430072688
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45420,6891,1.00 [0.94-1.05],0.9048850242745442
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,38909,380,1.07 [0.85-1.35],0.5696655406275537
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,39616,1087,1.12 [0.98-1.29],0.0918159788228298
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50415,643,1.02 [0.85-1.22],0.8387335890462951
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50048,276,1.04 [0.79-1.38],0.7661149666875842
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,38775,246,1.09 [0.82-1.45],0.5473304011795336
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",38649,120,0.95 [0.62-1.45],0.8180132029531313
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,49515,3049,0.92 [0.84-1.00],0.0498517241319137
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39035,506,1.22 [1.01-1.48],0.0428927715552215
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39110,581,1.03 [0.85-1.25],0.764111030866857
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39774,1245,0.92 [0.81-1.06],0.2416650623185987
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,38759,230,1.02 [0.75-1.38],0.8995111183945063
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50031,259,1.11 [0.84-1.47],0.4525900715832058
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,39710,1181,0.90 [0.79-1.04],0.1570993170389813
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,39473,944,0.90 [0.77-1.05],0.175745985992326
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,45529,137,1.11 [0.76-1.62],0.6002980027303102
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,48247,9718,1.00 [0.95-1.05],0.9297430107368004
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,46562,96,0.87 [0.54-1.43],0.5919451595106724
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,46579,113,0.83 [0.52-1.31],0.4168168402676753
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,50208,3818,0.89 [0.83-0.96],0.0032178448127979
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",50211,3814,0.89 [0.83-0.96],0.0034088338906569
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,46569,103,0.71 [0.43-1.16],0.17164083370445
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,49904,2382,0.97 [0.88-1.07],0.5158089519394453
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",41631,3102,1.01 [0.93-1.10],0.7972999569862798
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,50552,440,1.05 [0.85-1.31],0.6471825817205059
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,48693,163,1.46 [1.06-2.02],0.0213214871088058
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,47727,205,0.90 [0.65-1.26],0.5480521812256522
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,47801,279,0.93 [0.70-1.24],0.6360716756299138
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",38861,332,1.02 [0.79-1.31],0.8971866241150512
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46014,300,1.07 [0.82-1.40],0.6019345311513384
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4152,167,0.80 [0.56-1.16],0.2454283324300196
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4430,500,0.81 [0.65-1.00],0.0467121056486745
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,45838,124,1.14 [0.77-1.69],0.5096469126402834
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4096,114,1.02 [0.67-1.56],0.9229303043419445
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49323,3609,1.18 [1.09-1.26],1.2948377361459162e-05
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,49224,694,1.07 [0.90-1.27],0.4663722749561479
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,46110,718,0.84 [0.70-1.00],0.0536651535660629
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40035,1506,0.95 [0.84-1.08],0.4330453339092345
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50356,475,0.99 [0.80-1.22],0.8927280378293059
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),48360,321,1.02 [0.79-1.33],0.8690679551053635
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,46190,2344,1.03 [0.94-1.14],0.4925934284197413
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,48512,473,1.01 [0.82-1.25],0.926153656555416
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,48154,115,1.00 [0.65-1.55],0.9927024528072494
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48428,389,1.02 [0.81-1.30],0.8371052649369931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31384,3732,1.05 [0.97-1.13],0.2099183497636829
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,AV-block,42636,844,0.97 [0.83-1.14],0.7441686420020939
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50463,836,0.94 [0.80-1.10],0.4474546360699976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,28026,374,1.08 [0.85-1.37],0.5134390827364039
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42124,332,1.00 [0.78-1.29],0.980406586492174
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",41979,187,0.91 [0.64-1.29],0.6047465943767104
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,50575,99,1.03 [0.64-1.65],0.9083193659737436
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,43838,2046,1.02 [0.92-1.13],0.687818816939353
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47886,4076,1.07 [1.00-1.15],0.0578866765843464
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44119,14794,1.00 [0.97-1.04],0.8349852978745668
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47873,513,0.97 [0.79-1.20],0.8102869772767805
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Endocarditis,41936,144,1.10 [0.76-1.61],0.614352062406506
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",50173,2143,1.16 [1.05-1.28],0.002734561609146
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,45916,12713,1.03 [0.99-1.07],0.1814425659764211
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",45953,12750,1.03 [0.99-1.07],0.176854322028591
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",50246,148,0.65 [0.43-0.98],0.038749215190815
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33546,343,1.26 [0.99-1.59],0.0583111694595151
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33475,272,1.19 [0.91-1.56],0.1997150128400716
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,50294,2294,1.04 [0.95-1.15],0.3688093963314354
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,48779,207,0.77 [0.55-1.09],0.138323023287858
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",48221,4375,1.06 [0.99-1.13],0.1132930951438846
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49841,1085,1.04 [0.90-1.19],0.6223836923642528
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,42499,707,1.19 [1.01-1.40],0.0404836381540068
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49636,1640,1.04 [0.93-1.17],0.4839519091990844
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45229,1383,1.03 [0.91-1.17],0.636633505223675
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50393,301,0.98 [0.75-1.29],0.8988256503304527
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",50519,603,0.89 [0.73-1.08],0.2292896341797474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,47462,102,0.95 [0.60-1.52],0.8460217617691417
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other aneurysm,48191,152,1.00 [0.68-1.46],0.990983346691592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,42620,828,1.00 [0.85-1.17],0.9591707229493068
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48234,195,1.02 [0.73-1.43],0.8911938282626618
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48500,461,0.98 [0.78-1.22],0.8316634981491999
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,42144,352,1.18 [0.93-1.49],0.1690378930605769
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,47551,191,0.82 [0.58-1.17],0.2753209445791055
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,47453,93,1.29 [0.83-2.00],0.2613049323481883
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,47774,126,0.72 [0.46-1.12],0.1490417769503879
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,47624,264,1.00 [0.75-1.33],0.9849406522192014
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43812,2020,0.96 [0.86-1.06],0.430344311231383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,48107,107,0.90 [0.57-1.42],0.6469137471152391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49106,1067,0.97 [0.84-1.12],0.6567459389152073
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49356,674,1.32 [1.12-1.56],0.0008671765485328
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",48854,1206,0.97 [0.85-1.12],0.701768938679608
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28310,658,0.99 [0.82-1.18],0.8821088310551567
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48774,795,1.01 [0.86-1.20],0.8629294946230762
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48026,666,0.92 [0.77-1.11],0.4020410083343918
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49622,940,1.08 [0.93-1.25],0.3123754402848487
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50439,1284,0.98 [0.86-1.12],0.7733689662078227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,42470,678,1.05 [0.88-1.25],0.6006785262508507
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49345,663,1.35 [1.15-1.59],0.000306293734925
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,48024,376,0.91 [0.71-1.17],0.4713521458976849
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49818,1246,0.99 [0.87-1.13],0.8912951200723626
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49777,1317,0.99 [0.87-1.12],0.8482387090959373
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,48726,112,0.80 [0.51-1.27],0.3478292948400066
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,48199,161,0.84 [0.57-1.23],0.3588680183585838
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49211,455,1.03 [0.83-1.28],0.8027450663058239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48504,508,1.05 [0.86-1.28],0.6527629073780301
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,48200,840,0.83 [0.70-0.98],0.0270327066993667
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,48069,169,0.99 [0.69-1.42],0.9459364251578848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50127,1471,1.02 [0.91-1.16],0.7038109620680729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50339,704,0.86 [0.71-1.03],0.0908176447321565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",44247,2810,0.97 [0.88-1.06],0.4433866965574251
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,49300,7863,0.99 [0.94-1.05],0.7861563974563394
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50248,833,0.92 [0.78-1.08],0.3240781518242231
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",44551,3114,0.96 [0.88-1.05],0.3623173510701033
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41614,177,1.18 [0.85-1.65],0.3162877859432944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,49539,2692,1.02 [0.93-1.12],0.6255426697986559
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",44645,3208,1.00 [0.92-1.08],0.985928981158922
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Vascular dementia,49567,248,0.93 [0.68-1.26],0.6167173322506632
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Alzheimer disease,50576,656,1.09 [0.91-1.31],0.344268649007715
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34092,116,0.95 [0.61-1.48],0.8200701099621752
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Bell's palsy,47078,157,0.63 [0.42-0.94],0.0245623956560749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47882,961,0.91 [0.78-1.06],0.2120802453841843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral cysts,49783,451,0.85 [0.68-1.06],0.1554343095278415
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50420,630,0.83 [0.68-1.01],0.0571029994056861
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,49588,99,1.23 [0.80-1.90],0.347614042272893
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,50544,119,1.02 [0.67-1.55],0.936464296677546
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",49477,145,1.12 [0.77-1.63],0.5443172826345681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,47520,561,0.78 [0.63-0.96],0.017359604951049
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49630,2671,0.88 [0.80-0.96],0.0063126892509706
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,50494,1184,0.94 [0.82-1.08],0.4166218829742907
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,49403,5067,0.93 [0.87-1.00],0.0384946519075822
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,49827,105,0.91 [0.57-1.45],0.6883502362658058
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,50280,490,0.87 [0.70-1.08],0.204610266286507
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hydrocephalus,49453,121,1.03 [0.67-1.56],0.9043179254180076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,50538,139,1.18 [0.81-1.71],0.3991599453200881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,47066,145,0.85 [0.57-1.28],0.4449999242362658
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47076,155,1.31 [0.93-1.83],0.1173075624875605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Memory loss,49281,213,0.98 [0.71-1.35],0.9148646307708284
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,47652,693,0.86 [0.72-1.03],0.1111660999346323
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50438,622,0.81 [0.67-0.98],0.0332422424423261
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Motor neuron disease,34285,271,1.03 [0.78-1.36],0.8429672598741267
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50253,206,0.93 [0.67-1.30],0.6786182490199097
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49260,2339,0.95 [0.86-1.05],0.3317578112278835
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,47674,7389,0.94 [0.89-0.99],0.026364200796611
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,49881,392,0.76 [0.59-0.98],0.0333282302892036
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47729,808,1.00 [0.85-1.17],0.967873302424048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50431,579,1.12 [0.93-1.35],0.2296164501593892
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40229,1279,0.95 [0.83-1.09],0.4646161259074058
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,49475,143,1.10 [0.76-1.60],0.6182106405822251
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,49601,269,0.80 [0.60-1.08],0.1503516815395692
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,49628,318,0.97 [0.75-1.27],0.8334598270670175
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,47105,184,0.62 [0.43-0.90],0.0120922284212098
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other headache syndromes,47072,113,0.72 [0.46-1.15],0.1724015112369251
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,50344,1012,0.97 [0.83-1.12],0.6581081400924841
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,48056,1097,0.94 [0.82-1.08],0.4104941272814055
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Parkinson's disease,50532,843,0.91 [0.77-1.07],0.2586216720545929
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,49440,108,0.63 [0.39-1.03],0.0648987202501504
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,50575,148,1.21 [0.85-1.74],0.2926090993736241
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,50099,944,0.98 [0.84-1.13],0.7556006225972284
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,49946,94,0.95 [0.59-1.55],0.8447697808861794
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,50550,323,1.06 [0.82-1.36],0.6732719836542078
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,47021,100,0.76 [0.46-1.25],0.275558496780845
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,50576,663,1.08 [0.90-1.30],0.3899925050493296
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),49492,241,0.91 [0.67-1.24],0.559122976010051
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,49463,194,0.92 [0.65-1.29],0.6190429279217214
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,49774,765,0.70 [0.58-0.83],8.9744783519218e-05
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50232,460,0.93 [0.75-1.16],0.5290034202788751
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,48617,104,0.97 [0.61-1.53],0.88673560724365
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48627,114,1.32 [0.90-1.94],0.1560936829372948
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",50365,103,1.10 [0.71-1.72],0.6704287193512702
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,50057,285,0.72 [0.53-0.96],0.0267751278037174
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4107,122,0.99 [0.65-1.49],0.9491606381246668
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4978,197,0.88 [0.63-1.23],0.449255303521303
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,49451,182,0.97 [0.68-1.37],0.8427210341209292
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50153,2016,0.96 [0.86-1.06],0.4177825044330494
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49861,1348,0.91 [0.80-1.04],0.1634595523844557
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48946,433,1.07 [0.86-1.33],0.5465373244452492
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50410,1401,0.81 [0.71-0.93],0.0021798377231912
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,50556,134,1.32 [0.92-1.90],0.1261903823946445
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,50268,1259,0.80 [0.70-0.92],0.0015249991641676
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",50491,719,0.90 [0.75-1.08],0.2568668025984346
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,50397,346,0.89 [0.69-1.15],0.365268849926979
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,48629,116,1.07 [0.70-1.64],0.741454304547948
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,48640,127,0.86 [0.56-1.32],0.4869859822022284
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,48616,103,0.89 [0.55-1.44],0.6390535675119516
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50390,1383,0.99 [0.88-1.13],0.9328005675237374
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,49364,357,1.09 [0.86-1.38],0.4933677438854194
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,49104,95,1.50 [1.01-2.23],0.0455998881396107
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,49966,194,0.99 [0.71-1.38],0.9353247970836328
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,50309,537,0.85 [0.69-1.05],0.134430846760415
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,49386,377,0.88 [0.68-1.12],0.2969572593564824
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,50262,211,0.84 [0.60-1.17],0.2938385690408589
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49931,924,1.00 [0.86-1.16],0.9848516214974176
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,49546,277,1.23 [0.95-1.59],0.121330212834622
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,47451,4259,1.03 [0.95-1.10],0.4968254102470546
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,50237,465,0.83 [0.66-1.04],0.1140624904370773
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,50540,295,0.96 [0.73-1.26],0.7658581552774291
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49305,792,0.89 [0.75-1.06],0.1985111554798916
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,49897,125,0.93 [0.61-1.43],0.7457908955796542
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,50530,108,1.33 [0.89-1.99],0.1631174818021217
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,48679,166,1.05 [0.74-1.51],0.7736635110788107
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48802,289,0.68 [0.51-0.91],0.0106248274338492
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,48371,234,1.05 [0.78-1.42],0.7406319757736526
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,49131,122,0.97 [0.64-1.48],0.8948490395134265
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",48257,120,0.90 [0.58-1.39],0.6232406163730415
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,49175,168,0.80 [0.55-1.17],0.252668964512264
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",49386,379,1.07 [0.84-1.35],0.583980788851503
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,48763,250,1.04 [0.78-1.39],0.7737566139798349
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,48357,220,0.77 [0.56-1.08],0.1284595815308022
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,48303,166,0.80 [0.55-1.17],0.2588818459676092
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,46721,3529,0.92 [0.85-0.99],0.0336216525507802
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,48651,138,0.97 [0.65-1.45],0.878926476036029
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50076,807,1.06 [0.91-1.25],0.4468151199514045
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,49383,114,1.14 [0.75-1.73],0.5390974941044488
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),49594,325,0.98 [0.76-1.27],0.904319568412004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,50164,171,0.98 [0.69-1.40],0.9140063802627038
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,50490,236,0.66 [0.48-0.92],0.0143508226171545
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,50324,254,0.71 [0.52-0.97],0.0301978820263898
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,50110,117,1.12 [0.74-1.70],0.6034322625270564
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,50113,120,1.13 [0.76-1.69],0.5479904090256142
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,50378,1760,0.92 [0.82-1.03],0.1354849091016777
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,49879,1261,0.95 [0.83-1.09],0.4659477122746571
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,48866,248,0.88 [0.65-1.19],0.3953613807106628
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,48781,163,0.85 [0.58-1.24],0.3925559782725605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,50100,145,0.88 [0.59-1.31],0.5370711789459548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50369,414,0.79 [0.62-1.01],0.0550955727207853
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,50075,120,0.86 [0.55-1.33],0.4915024888284549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza,46635,234,1.49 [1.15-1.93],0.002660511572921
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),46630,229,1.48 [1.14-1.93],0.003200528429197
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),34648,229,0.87 [0.64-1.20],0.3964504300963064
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,50315,549,0.96 [0.79-1.17],0.6785723929890787
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37349,3450,0.96 [0.88-1.04],0.2831800542093534
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37819,3400,0.97 [0.89-1.05],0.3982391054669537
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),49782,269,1.36 [1.06-1.75],0.0174282918015707
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",46561,160,1.50 [1.10-2.04],0.0102045390255336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bronchiectasis,43846,691,1.19 [1.01-1.41],0.0361731147890125
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43269,114,1.20 [0.80-1.79],0.3870758532172708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,48591,5436,0.99 [0.93-1.05],0.7592080627111623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",47877,136,1.05 [0.71-1.55],0.8054337825249702
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,48042,301,1.27 [1.00-1.62],0.0541985360748416
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",50181,2326,1.02 [0.92-1.12],0.7214803721356498
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,47948,207,0.89 [0.64-1.24],0.482308134202783
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,46528,10289,1.00 [0.96-1.05],0.8514823190769951
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48455,714,0.96 [0.81-1.14],0.6525823348274303
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,48468,613,1.18 [0.99-1.41],0.065996190992104
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Emphysema,43763,608,1.14 [0.95-1.36],0.1558227688750323
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48046,556,1.33 [1.11-1.59],0.00184572888807
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,50145,3744,1.09 [1.01-1.17],0.0294233823122542
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,48112,622,1.26 [1.06-1.50],0.0079100332786876
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Later onset COPD,48617,1713,0.94 [0.84-1.05],0.2720353086566258
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,50551,646,1.03 [0.86-1.24],0.7469397362128221
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,47942,201,1.04 [0.75-1.44],0.804165984059438
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50081,1899,1.16 [1.04-1.28],0.0058656720992151
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,50111,3895,1.07 [0.99-1.15],0.0798429814798401
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49378,1637,0.99 [0.88-1.11],0.8890705550054604
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other pleural conditions,46316,100,1.22 [0.79-1.87],0.3774848944878732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50396,773,1.27 [1.09-1.48],0.0023967780613405
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,50366,2542,1.03 [0.94-1.13],0.479117551833383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,48168,1952,1.13 [1.02-1.25],0.0213432780460408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural plaque,46521,305,1.09 [0.84-1.42],0.4968121397252493
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",49649,3248,1.08 [1.00-1.17],0.0479286372783065
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,50421,516,1.07 [0.87-1.31],0.5360556411535718
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumothorax,46447,231,1.14 [0.85-1.53],0.3694770665519512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pollen allergy,50531,469,0.97 [0.78-1.20],0.7634839478415698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,49749,126,1.62 [1.16-2.28],0.0049513693848067
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,34527,108,0.90 [0.57-1.42],0.6454913437084088
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50038,1856,1.16 [1.05-1.29],0.0045607423275447
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,48292,551,0.95 [0.78-1.16],0.5987918980317797
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Viral pneumonia,46893,492,0.94 [0.76-1.16],0.5756649806661177
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",49809,407,0.93 [0.73-1.17],0.5206283745006675
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23311,223,0.98 [0.72-1.35],0.9222980751442932
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35737,124,1.10 [0.74-1.65],0.6366327265041911
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,50264,285,0.82 [0.61-1.09],0.1729378458549041
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute gastritis,38078,180,0.94 [0.66-1.33],0.7106030504899326
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,46966,360,1.07 [0.84-1.36],0.6023528097159441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute peritonitis,49664,176,1.14 [0.81-1.59],0.4538613546636703
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,48828,141,0.69 [0.46-1.05],0.0823723107019037
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,38752,854,0.74 [0.63-0.88],0.0004934503273478
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",46807,201,1.25 [0.92-1.70],0.1568392042976636
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",49757,201,1.25 [0.92-1.69],0.1585452699405716
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,47007,401,1.31 [1.06-1.63],0.011931157466516
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,48548,1942,0.94 [0.85-1.05],0.2832543533466126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,38506,608,0.98 [0.81-1.18],0.8416028431152229
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,46706,100,0.64 [0.39-1.06],0.0824114405858556
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",50299,201,0.94 [0.68-1.31],0.718542130767033
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,47437,242,0.88 [0.64-1.20],0.409942630765381
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Collagenous colitis,47278,159,0.95 [0.66-1.38],0.7978888437576726
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50278,361,1.03 [0.81-1.31],0.792042535466063
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,50071,3276,0.92 [0.85-1.00],0.0594040467658209
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,47303,184,1.03 [0.73-1.44],0.8726615947768754
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49887,135,0.98 [0.65-1.46],0.9124495167729164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47292,173,1.08 [0.77-1.53],0.6531248285827185
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,49132,449,0.98 [0.79-1.22],0.8552254924326372
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,45374,4359,0.90 [0.83-0.96],0.0033675388282969
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,50336,357,0.86 [0.67-1.11],0.2456904391744383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,50337,1650,1.07 [0.95-1.19],0.2640872367130686
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46321,8423,0.93 [0.88-0.98],0.0072607217020999
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49758,1075,1.00 [0.87-1.15],0.965088382565864
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50411,923,1.06 [0.91-1.23],0.4604464074854287
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48906,223,0.79 [0.57-1.09],0.1481463499995
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,48621,129,0.85 [0.56-1.29],0.4428604796206852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49963,2768,1.00 [0.92-1.10],0.9224462174702496
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of tongue,48649,216,0.97 [0.70-1.33],0.8490224426873864
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49351,2745,0.97 [0.89-1.06],0.5534144449974803
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,41802,6189,0.97 [0.91-1.02],0.2513352862625786
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,38287,389,0.99 [0.78-1.25],0.9426826056878964
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50411,313,0.94 [0.72-1.22],0.6231984572944362
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50404,108,1.21 [0.80-1.83],0.3733496996109642
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,48931,244,0.97 [0.72-1.31],0.8457156485852522
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35897,284,1.06 [0.81-1.39],0.6503268108901448
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,38975,1077,0.82 [0.71-0.96],0.0103331472831772
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,38607,709,0.93 [0.78-1.11],0.434107613036834
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,42783,4885,0.90 [0.84-0.96],0.0020456591640174
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38955,1057,0.97 [0.84-1.12],0.6634950600513687
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39165,16222,0.95 [0.92-0.99],0.0133259751904976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,49462,2267,1.00 [0.91-1.11],0.9295945782571932
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,48790,107,0.91 [0.58-1.43],0.6842851926049839
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,37525,2465,0.92 [0.84-1.02],0.1061629428061776
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",48809,122,0.91 [0.59-1.40],0.6672707226898366
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,47388,6373,0.92 [0.86-0.97],0.0038328785254045
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,50417,100,1.28 [0.84-1.95],0.2531490465637019
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impaction of intestines,35724,111,1.54 [1.07-2.22],0.0200379351724778
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,42787,1772,0.98 [0.88-1.10],0.7768521874181368
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41211,196,0.96 [0.69-1.35],0.8321635025582771
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,35798,185,1.03 [0.73-1.44],0.8706430226285581
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47477,282,0.92 [0.69-1.22],0.550236925862919
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36694,1081,0.87 [0.75-1.01],0.0621302493800687
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,50517,724,1.15 [0.97-1.35],0.1054340275100099
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48607,1488,1.00 [0.89-1.13],0.9758223736148548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49092,1973,0.93 [0.83-1.03],0.1720544198716192
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38267,369,0.85 [0.66-1.10],0.2132715284655237
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,39081,1183,0.76 [0.66-0.88],0.0001625149837178
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50477,271,1.07 [0.81-1.40],0.6361181223639536
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,41151,136,0.99 [0.66-1.47],0.941866621213028
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38267,2654,0.95 [0.87-1.04],0.2816677890086959
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47159,553,1.05 [0.86-1.28],0.6212028249696309
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,46908,302,0.91 [0.70-1.20],0.5219714835228493
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,39022,3409,0.94 [0.87-1.02],0.1472709339192816
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,46654,11041,0.95 [0.91-1.00],0.0428846762456313
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48602,413,1.04 [0.83-1.30],0.748412604022098
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,50039,1352,1.10 [0.97-1.24],0.1434748956158707
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39192,1294,0.80 [0.70-0.92],0.0012457727925931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,46903,297,0.83 [0.62-1.10],0.1923954440158383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50282,794,1.02 [0.87-1.20],0.8016575552121783
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39759,1861,0.85 [0.76-0.95],0.0037813464750276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,49492,2297,1.01 [0.92-1.11],0.8368547649092591
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49039,356,0.92 [0.72-1.19],0.5344175332428813
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,38977,3364,0.91 [0.83-0.98],0.0184569765861622
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),41814,3916,0.95 [0.88-1.03],0.198676126180693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,48877,190,0.89 [0.63-1.25],0.4936162436369528
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48849,1730,0.95 [0.85-1.07],0.4208170756471215
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36287,674,1.02 [0.86-1.22],0.798483782916279
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50384,125,1.12 [0.75-1.66],0.5920796015930943
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36572,959,0.99 [0.85-1.14],0.8442314833804732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47482,287,0.99 [0.75-1.31],0.9596765848841472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,50557,110,1.15 [0.76-1.76],0.5098251816991644
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,48698,232,1.08 [0.80-1.45],0.605825074536852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Toxic colitis,47229,110,0.55 [0.34-0.90],0.017157238135454
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38411,513,0.78 [0.63-0.97],0.0263353917177404
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,47432,313,0.97 [0.74-1.27],0.8278325348974819
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47379,260,0.96 [0.72-1.29],0.7821218969073184
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,41556,541,0.88 [0.72-1.08],0.2136311914265031
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,35953,340,0.84 [0.65-1.09],0.1987891927824038
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,41536,521,1.01 [0.83-1.24],0.914072403630693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Volvulus,35771,158,0.65 [0.44-0.97],0.0367101979885682
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,50416,569,1.00 [0.83-1.22],0.9729368319745968
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,49947,146,0.90 [0.61-1.33],0.5997715885467081
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46563,307,0.91 [0.70-1.20],0.5163415576143107
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49329,1354,1.09 [0.97-1.24],0.157623459097167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48310,335,0.84 [0.65-1.10],0.2051700941897133
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47054,798,0.94 [0.80-1.11],0.4690222066262008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,49985,548,1.12 [0.92-1.35],0.2536628791650757
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50383,946,1.04 [0.89-1.21],0.6160502406154966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,49532,95,1.09 [0.68-1.74],0.7195121488526703
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,47530,6256,0.96 [0.90-1.02],0.1766192445598162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49688,878,0.98 [0.84-1.15],0.8451651970573347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49432,622,0.95 [0.79-1.15],0.6200983234489549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49805,1830,1.10 [0.99-1.22],0.0854716070791801
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",50543,108,0.97 [0.62-1.52],0.9051208450431484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,46367,111,0.72 [0.45-1.15],0.1646020029165403
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48911,101,0.87 [0.54-1.40],0.5622352257238004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,49966,529,1.09 [0.89-1.33],0.3927520634960689
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47139,883,0.79 [0.67-0.93],0.0055221946112938
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,46380,124,1.24 [0.84-1.83],0.2718093413106447
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,50409,162,1.21 [0.86-1.71],0.2760795267307044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48347,372,1.22 [0.98-1.54],0.0805749301261875
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50177,376,0.95 [0.75-1.21],0.6859073956464241
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,49562,125,1.31 [0.89-1.92],0.1698647963816344
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,46385,129,0.92 [0.60-1.40],0.6897926732431832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,49446,3190,0.93 [0.85-1.01],0.0825150511772316
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47214,958,0.81 [0.69-0.95],0.0095816986273605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,46388,132,1.19 [0.81-1.74],0.3681132866668757
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50404,603,0.90 [0.74-1.10],0.3035607422582693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,49569,132,0.64 [0.41-0.99],0.0457821170397207
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50294,493,0.88 [0.71-1.09],0.2308311905690597
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,50471,624,0.94 [0.78-1.13],0.5032261373833633
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46497,241,0.84 [0.62-1.15],0.2781293190999135
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46786,530,0.89 [0.72-1.09],0.2658979918857815
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50450,603,0.94 [0.78-1.14],0.5558494062555555
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",46714,458,1.08 [0.87-1.33],0.4740811025413635
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,50515,268,1.11 [0.84-1.46],0.4611302481517287
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,43377,214,0.78 [0.56-1.09],0.1388690251904428
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46029,11040,0.92 [0.87-0.96],0.0001220065208877
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43254,8265,0.88 [0.84-0.93],3.246193770374694e-06
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,43311,148,1.19 [0.83-1.70],0.3336194295094264
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43815,300,1.06 [0.81-1.38],0.6768412306839249
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43867,352,1.09 [0.85-1.38],0.5053884495479982
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,50090,180,0.93 [0.66-1.32],0.6863395467519089
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",43715,200,0.95 [0.68-1.33],0.7537565124825756
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37196,2207,0.88 [0.80-0.98],0.0165192847326746
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50304,362,1.14 [0.90-1.44],0.2851984826971747
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44389,874,0.96 [0.82-1.13],0.6378715124259451
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,42742,14219,0.93 [0.89-0.96],0.0002076892359684
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46679,222,0.92 [0.67-1.27],0.619001484305882
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,43460,297,1.09 [0.84-1.42],0.5055993514880306
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44276,1113,0.94 [0.81-1.08],0.3575176382977808
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,48750,5235,0.95 [0.89-1.02],0.1501791068560808
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43690,527,0.71 [0.57-0.88],0.0020756384784728
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,43593,430,0.78 [0.61-0.99],0.0377675269671856
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43430,267,0.95 [0.72-1.27],0.7527250961228368
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,49327,133,1.06 [0.71-1.58],0.7793924525218634
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38300,3311,0.86 [0.79-0.93],0.0002620326877502
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36171,1182,1.08 [0.95-1.23],0.240226244196525
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50425,1166,1.13 [1.00-1.29],0.0572934531683498
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35135,146,0.85 [0.57-1.27],0.4227784731049774
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35631,642,0.85 [0.70-1.03],0.1019774243103595
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43761,598,0.86 [0.71-1.05],0.137830690272484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36236,1247,0.86 [0.75-0.98],0.0260122456454496
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,43626,111,0.91 [0.57-1.43],0.6705217185933404
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44758,1243,1.07 [0.94-1.21],0.3357601020328282
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44113,598,1.03 [0.85-1.24],0.7773946097168355
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36157,1168,0.84 [0.73-0.97],0.0159051777168182
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,43320,157,1.07 [0.74-1.54],0.7254111673084289
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",43286,123,0.89 [0.58-1.37],0.5918541430997208
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,46602,145,1.21 [0.85-1.73],0.2967452461981738
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,49811,3354,0.88 [0.81-0.96],0.0026809244837616
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48659,2202,0.85 [0.76-0.94],0.00167562319337
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50296,883,1.13 [0.97-1.31],0.1228310426078424
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,39856,4867,0.88 [0.82-0.94],0.0001634063305123
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35113,124,0.77 [0.49-1.19],0.2347588106989284
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,43346,183,1.14 [0.82-1.58],0.4411516560563928
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35083,94,1.21 [0.77-1.91],0.4064352261677729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35233,244,0.71 [0.51-0.98],0.0348741827659412
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46925,468,0.92 [0.74-1.14],0.4361596864262255
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,47203,746,0.92 [0.77-1.10],0.3567766863230351
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,50511,192,0.83 [0.58-1.18],0.3003164167840476
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47063,3548,0.98 [0.91-1.06],0.6515397093103025
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43358,195,1.10 [0.80-1.51],0.5760037729999459
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35254,265,0.61 [0.45-0.84],0.0021742264686046
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44929,1414,1.01 [0.89-1.14],0.8983522109737142
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39202,4213,0.87 [0.81-0.94],0.0003574912796006
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,49375,181,1.13 [0.81-1.58],0.4701827091857287
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,50539,139,0.96 [0.64-1.43],0.8366370109776253
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43325,162,0.99 [0.68-1.43],0.9469014685143248
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45601,2438,0.96 [0.87-1.05],0.3718684200892956
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,43337,174,1.33 [0.97-1.84],0.0764211272949802
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38173,3184,0.92 [0.84-1.00],0.050192568626438
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46671,214,0.87 [0.63-1.21],0.4190649472349959
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,43268,105,1.05 [0.67-1.63],0.8397273626439801
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,43822,307,0.72 [0.54-0.96],0.0253433577918457
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44246,1083,0.99 [0.86-1.14],0.9000707588968546
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49882,688,1.06 [0.89-1.27],0.4955453195328482
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44644,1129,1.04 [0.91-1.20],0.5438558825334243
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50318,856,1.14 [0.98-1.33],0.0897124866636751
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,50532,104,1.25 [0.82-1.90],0.3077111050138371
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43532,369,0.95 [0.74-1.21],0.6604574717379081
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40021,1485,0.95 [0.84-1.07],0.3741334996925934
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44294,1131,1.04 [0.91-1.20],0.5400144231989474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43605,442,0.67 [0.53-0.85],0.0011968104684647
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35096,107,0.75 [0.46-1.21],0.2341449870002268
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,39861,4872,0.96 [0.90-1.03],0.2947596203122743
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36270,1281,0.89 [0.78-1.02],0.1014152317812179
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,49649,455,1.16 [0.94-1.43],0.1677239548827657
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",50449,130,0.79 [0.51-1.21],0.2751849946637196
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",46329,97,0.83 [0.51-1.35],0.4588480054236564
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35131,142,0.88 [0.59-1.32],0.5502924027977829
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,43712,197,0.79 [0.56-1.12],0.1864175234675344
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35883,894,1.08 [0.93-1.26],0.3036960730982326
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43767,604,0.72 [0.59-0.88],0.0012568030797231
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44019,504,0.96 [0.78-1.18],0.7012038499453395
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,43888,373,0.85 [0.66-1.10],0.2213558713270325
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,39542,117,1.38 [0.96-2.00],0.085302314060785
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",50540,112,1.25 [0.83-1.87],0.2814800567237189
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44320,1157,0.88 [0.77-1.02],0.0802325477037948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],49369,175,0.81 [0.56-1.17],0.253590148020312
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,48195,5032,0.91 [0.85-0.97],0.0055700046803651
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43420,257,0.66 [0.48-0.90],0.0085657530911893
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44578,1063,0.96 [0.83-1.11],0.6151357564417933
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,47831,456,0.82 [0.65-1.03],0.0840012589092942
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,43916,401,1.03 [0.82-1.30],0.7714568098228076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,46567,3052,0.95 [0.87-1.03],0.2178532224311949
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45531,2016,1.00 [0.90-1.10],0.9380635408639524
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],43270,107,1.21 [0.80-1.84],0.3603983024350865
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49453,259,0.80 [0.59-1.09],0.1546479746121321
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43480,317,0.91 [0.70-1.19],0.4983409979164762
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,43311,148,0.70 [0.47-1.06],0.0956279096069273
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35103,114,0.76 [0.48-1.21],0.2465851107417191
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,48517,3086,1.13 [1.04-1.23],0.0036518385680201
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20389,100,1.05 [0.67-1.66],0.8230161202375641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26575,110,0.91 [0.58-1.43],0.6717895193494732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49949,633,1.12 [0.94-1.34],0.2075969200902274
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,49481,165,1.18 [0.83-1.66],0.3581060908578748
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48438,3007,1.19 [1.09-1.29],4.022265076666474e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,50155,164,1.21 [0.86-1.70],0.2840461279962888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,50092,588,1.08 [0.89-1.30],0.4427146535969201
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,44570,460,0.82 [0.65-1.03],0.0879185224897654
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dialysis,45590,159,1.60 [1.18-2.17],0.0027045696133702
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22038,3251,0.95 [0.87-1.03],0.202019202154558
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26806,341,0.86 [0.66-1.11],0.2432795707430325
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,20468,179,0.90 [0.63-1.28],0.5440464279640729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20690,401,0.81 [0.63-1.03],0.0816066498242221
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21291,1002,0.89 [0.76-1.04],0.1305045872491217
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42188,10506,0.99 [0.95-1.04],0.7795840894691457
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,50158,167,1.16 [0.83-1.64],0.3894493702378032
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,18994,207,1.01 [0.74-1.39],0.9415562217393162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,45413,572,1.08 [0.89-1.31],0.4191905157906148
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21339,2552,0.93 [0.84-1.02],0.1131404654373417
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26731,405,0.82 [0.64-1.04],0.1052953672810721
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19018,231,1.17 [0.88-1.56],0.2846498259534418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,26811,128,0.56 [0.36-0.88],0.0120322558796492
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20598,309,0.83 [0.63-1.09],0.1693798698888531
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44261,151,0.94 [0.64-1.38],0.7516101881377817
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22750,2461,0.93 [0.85-1.03],0.1577387603705948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18895,108,0.84 [0.53-1.34],0.466954604666592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20433,144,0.80 [0.53-1.20],0.2755591444772377
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",50549,121,0.75 [0.48-1.17],0.2043632692352947
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",50557,129,0.84 [0.55-1.28],0.4169284167457302
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,48525,4415,0.97 [0.91-1.04],0.4420388263212865
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45508,1398,0.94 [0.83-1.07],0.3397101654172365
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26584,119,0.65 [0.41-1.04],0.0701791037827455
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50441,937,1.13 [0.97-1.31],0.1070541805538699
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19093,306,0.71 [0.54-0.94],0.0176314093977307
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19068,281,1.02 [0.78-1.35],0.8764008378953254
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19014,227,0.78 [0.57-1.08],0.1359021284132958
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,50500,142,1.01 [0.68-1.49],0.9685154254768938
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,47504,3394,0.98 [0.90-1.06],0.5997730021392336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26537,211,0.84 [0.61-1.18],0.3153633109465529
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20439,150,0.86 [0.58-1.28],0.4620404342893003
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20659,370,0.79 [0.61-1.01],0.0629909060106738
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20401,112,0.90 [0.57-1.41],0.6363519898552599
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20492,203,0.81 [0.58-1.14],0.2359351652308583
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45506,665,1.09 [0.92-1.30],0.3267254363027605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,49815,311,1.19 [0.93-1.53],0.1612921059117764
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20601,312,0.89 [0.68-1.16],0.390888500850553
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20397,108,0.92 [0.58-1.44],0.7066325181790214
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20940,651,1.02 [0.86-1.23],0.7928046780765061
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20452,163,0.90 [0.62-1.31],0.5811849098557115
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20878,589,1.02 [0.85-1.24],0.8074426311854327
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,50083,92,1.39 [0.90-2.15],0.1339162182882545
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19047,260,1.04 [0.78-1.38],0.8113925290782913
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,50084,5243,1.11 [1.04-1.18],0.0012491574683597
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",45078,237,1.17 [0.88-1.56],0.2742397945886402
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45688,257,1.30 [0.99-1.70],0.0626078806295931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49428,112,1.26 [0.84-1.89],0.2553315260638457
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44542,432,0.99 [0.79-1.24],0.92374069573923
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50099,783,1.16 [0.99-1.36],0.0629525999924629
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20432,143,1.32 [0.93-1.87],0.1154818223995325
